These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34561814)

  • 21. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Relative Permittivity Approach for Fast Drug Solubility Screening of Solvents and Excipients in Lipid-Based Delivery.
    Niederquell A; Dujovny G; Probst SE; Kuentz M
    J Pharm Sci; 2019 Oct; 108(10):3457-3460. PubMed ID: 31255684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Digestion-In Situ Absorption Setup Employing a Physiologically Relevant Value of the Membrane Surface Area/Volume Ratio for Evaluating Performance of Lipid-Based Formulations: A Comparative Study with an In Vitro Digestion-Permeation Model.
    Tanaka Y; Arai H; Hidaka A; Noda S; Imai K; Tsujisawa F; Yagi H; Sakuma S
    Mol Pharm; 2024 Jul; 21(7):3459-3470. PubMed ID: 38809159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.
    Williams HD; Trevaskis NL; Yeap YY; Anby MU; Pouton CW; Porter CJ
    Pharm Res; 2013 Dec; 30(12):2976-92. PubMed ID: 23824582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis.
    Shah MB; Martin JE; Schroeder TJ; First MR
    Transplantation; 1999 Jun; 67(11):1411-7. PubMed ID: 10385078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tools for Early Prediction of Drug Loading in Lipid-Based Formulations.
    Alskär LC; Porter CJ; Bergström CA
    Mol Pharm; 2016 Jan; 13(1):251-61. PubMed ID: 26568134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic lipolysis rate for systematic design of lipid-based formulations.
    Jacobsen AC; Kabedev A; Sinko PD; Palm JE; Bergström CAS; Teleki A
    Drug Deliv Transl Res; 2023 May; 13(5):1288-1304. PubMed ID: 36209313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the use of modified in vitro digestion assays for the evaluation of ritonavir loaded solid lipid-based formulations.
    Andreadis II; Schulzen A; Quodbach J; Bergström CAS
    Eur J Pharm Sci; 2023 Oct; 189():106524. PubMed ID: 37433412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption Periods.
    Crum MF; Trevaskis NL; Pouton CW; Porter CJ
    Mol Pharm; 2017 Feb; 14(2):394-405. PubMed ID: 28002666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations.
    Williams HD; Sassene P; Kleberg K; Bakala-N'Goma JC; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Carrière F; Müllertz A; Porter CJ; Pouton CW
    J Pharm Sci; 2012 Sep; 101(9):3360-80. PubMed ID: 22644939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs.
    Suys EJA; Brundel DHS; Chalmers DK; Pouton CW; Porter CJH
    J Control Release; 2021 Mar; 331():45-61. PubMed ID: 33450318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and dynamics of glyceride lipid formulations, with propylene glycol and water.
    Warren DB; Chalmers DK; Pouton CW
    Mol Pharm; 2009; 6(2):604-14. PubMed ID: 19260675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier.
    Van Speybroeck M; Williams HD; Nguyen TH; Anby MU; Porter CJ; Augustijns P
    Mol Pharm; 2012 Sep; 9(9):2750-60. PubMed ID: 22870936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations.
    Stillhart C; Dürr D; Kuentz M
    J Pharm Sci; 2014 Apr; 103(4):1194-203. PubMed ID: 24515977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID; Thomson M; Kelly DA
    Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
    Trull A; Steel L; Sharples L; Stewart S; Parameshwar J; McNeil K; Wallwork J
    Ther Drug Monit; 1999 Feb; 21(1):17-26. PubMed ID: 10051050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoral use in the cardiac transplant recipient.
    Valantine H
    Transplant Proc; 2000 May; 32(3A Suppl):27S-44S. PubMed ID: 10814748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Elucidation and Prediction of Absorption Behavior After Oral Administration of Poorly Water-Soluble Drugs as Different Lipid-Based Formulations].
    Tanaka Y
    Yakugaku Zasshi; 2023; 143(9):721-727. PubMed ID: 37661438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.